Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong, Si-Wei; Ma, Jianqun; Feng, Fen; Fu, Wen; Shu, Shan-Rong; Ma, Tianjiao; Wu, Caixia; Liu, Guo-Chang; Zhu, Jinhong.
; 8(15): 25300-25309, 2017 Apr 11.
Artigo em Inglês | MEDLINE | ID: mdl-28445975
Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population.
Dissecting Molecular Mechanisms in Bile Acid Diarrhea.
Role of fibroblast growth factor receptor 4 in cancer.
A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.
Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma.
Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.
Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex.
Frequent methylation of the KLOTHO gene and overexpression of the FGFR4 receptor in invasive ductal carcinoma of the breast.